Izafe Group

0,59 SEK

+7,27 %

Mindre end 1K følgere

IZAFE B

First North Stockholm

Medical Equipment & Services

Health Care

Oversigt

Finansielt overblik og estimater

Ejerskab

Investorkonsensus

+7,27 %

-14,24 %

+63,43 %

+138,87 %

+175,70 %

+147,90 %

+81,26 %

-81,26 %

-83,00 %

iZafe Group is a Life Science company focused on the development and marketing of digital medical solutions for home medication management. The company offers, among other things, a medication robot, SaaS solutions and a connected dosing bag. The products aim to reduce the risk of medication errors. Customers include individuals, pharmaceutical companies and public and private healthcare providers globally. iZafe Group is headquartered in Stockholm.

Markedsværdi

215,48 mio. SEK

Aktieomsætning

2,12 mio. SEK

Omsætning

7,95 mio.

EBIT %

-244,4 %

P/E

-

Udbytteafkast, %

-

Omsætning og EBIT-margin

Omsætning mio.

EBIT-% (adj.)

EPS og udbytte

EPS (adj.)

Udbytte %

Finanskalender

16.2

2026

Årsrapport '25

28.4

2026

Delårsrapport Q1'26

1.9

2026

Delårsrapport Q2'26

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Pressemeddelelse28.11.2025, 08.15

Board Member Increases Shareholding in iZafe Group

Pressemeddelelse21.11.2025, 07.30

iZafe Group strengthens its Nordic expansion through strategic partnership and first major deal in Norway

Pressemeddelelse20.11.2025, 07.30

iZafe Group signs distribution agreement with Skand for the launch of Dosell on the Icelandic market

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Pressemeddelelse17.11.2025, 09.00

iZafe Group’s Business Unit Manager, Helena Kolvik, acquires shares in the company

Pressemeddelelse6.11.2025, 07.30

Monthly Update – October: Growth, Integration and International Expansion

Selskabsmeddelelse3.11.2025, 07.30

iZafe Group’s quarterly report Q3, July–September 2025

Pressemeddelelse29.10.2025, 12.20

Nomination Committee appointed ahead of the 2026 Annual General Meeting of iZafe Group AB

Pressemeddelelse7.10.2025, 06.30

September Newsletter – Acquisition, Expansion and Growing Potential

Pressemeddelelse3.10.2025, 10.00

iZafe Group Board Members Acquire Shares

Selskabsmeddelelse30.9.2025, 19.15

iZafe Group acquires its distributor in the Netherlands – expects ARR targets to be reached earlier than planned

Pressemeddelelse8.9.2025, 07.15

Monthly Update – August: Continued Growth, Strong Interest, and Preparations for a Busy Fall

Selskabsmeddelelse29.8.2025, 06.30

iZafe Group Q2 Interim Report, April-June 2025

Pressemeddelelse8.8.2025, 08.05

Monthly Update July – Summer Calm, Stress Test and Continued Momentum

Pressemeddelelse9.7.2025, 07.00

iZafe Group signs agreement with AddSecure Smart Care Oy to launch Dosell in Finland

Pressemeddelelse7.7.2025, 09.00

Monthly Update June – New Share Issue, Shareholder Campaign, and Continued International Growth

Selskabsmeddelelse27.6.2025, 13.00

iZafe Group resolves on a directed share issue of approximately SEK 10 million

Pressemeddelelse5.6.2025, 06.30

Monthly Update May – Surpassing 1,000 Units and Growing Strategic Partnerships

Pressemeddelelse3.6.2025, 12.15

Dosell Reaches 1,000 Units in Operation – Celebrates Milestone with Investor Event in Stockholm

Pressemeddelelse20.5.2025, 11.15

iZafe signs Letter of Intent with JDM Innovation with the goal to initiate a strategic partnership in Europe

Pressemeddelelse8.5.2025, 05.30

April Monthly Report – Continued Growth as We Approach 1,000 Active Units

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.